Related Experiment Video
Updated: Jan 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Development of Insulin Bolus Calculators in Type 1 Diabetes Using a Framework Based on Real-World Data, Digital Twins
Objective:
Precise mealtime insulin bolus (MIB) dosing is essential in type 1 diabetes (T1D) to minimize glucose excursions from carbohydrate intake. Traditional MIB formulas, based on glucose concentration at mealtime, are suboptimal and do not exploit real-time data from continuous glucose monitoring (CGM). Existing methods that incorporate CGM data often rely on empirical rules or are developed in-silico, limiting their applicability to real-world conditions. This work investigates a framework combining machine learning (ML) algorithms, digital twins (DTs) and real-world data, to improve the assessment, tuning, and development of MIB dosing algorithms.
Methods:
We utilized ReplayBG, a DT for T1D, to: i) evaluate a published linear ML model (Noaro et al.), originally developed in-silico, on real-world data from 30 free-living subjects; ii) recalibrate this model to fit the real-world dataset; and iii) train and test nonlinear gradient-boosting models (XGBoost, LightGBM) developed entirely on real data through DT simulations.
Results:
Progressing to DT-enhanced models, we observed improvements in glucose control. The recalibrated linear and nonlinear models increased time-in-range (up to 80.6% with LightGBM vs. 75.6% for Noaro et al.) and reduced time-above-range. Risk metrics reflecting hypo/hyperglycemia also improved.
Conclusions:
These findings demonstrate that a DT-based framework grounded in real-world data supports both the refinement and development of bolus calculators, achieving performance gains beyond the original in-silico model.
Significance:
DTs allow the use of real-world data to develop, validate and extend the domain of validity of new MIB formulas, paving the way for practical applications of ML tailored solutions for T1D.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

